173 related articles for article (PubMed ID: 17096069)
1. Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats.
Ueki M; Koda M; Yamamoto S; Matsunaga Y; Murawaki Y
J Gastroenterol; 2006 Oct; 41(10):996-1004. PubMed ID: 17096069
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
Zhou Y; Tong X; Ren S; Wang X; Chen J; Mu Y; Sun M; Chen G; Zhang H; Liu P
J Ethnopharmacol; 2016 Aug; 190():83-90. PubMed ID: 27282665
[TBL] [Abstract][Full Text] [Related]
3. siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats.
George J; Tsutsumi M
Gene Ther; 2007 May; 14(10):790-803. PubMed ID: 17344905
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model.
Kim MY; Baik SK; Park DH; Jang YO; Suk KT; Yea CJ; Lee IY; Kim JW; Kim HS; Kwon SO; Cho MY; Ko SB; Chang SJ; Um SH; Han KH
J Gastroenterol; 2008; 43(11):889-96. PubMed ID: 19012043
[TBL] [Abstract][Full Text] [Related]
5. Preventive effects of ME3738 on hepatic fibrosis induced by bile duct ligation in rats.
Maeda K; Koda M; Matono T; Sugihara T; Yamamoto S; Ueki M; Murawaki Y; Yamashita N; Nishiyama S
Hepatol Res; 2008 Jul; 38(7):727-35. PubMed ID: 18328066
[TBL] [Abstract][Full Text] [Related]
6. An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells.
Kurikawa N; Suga M; Kuroda S; Yamada K; Ishikawa H
Br J Pharmacol; 2003 Jul; 139(6):1085-94. PubMed ID: 12871826
[TBL] [Abstract][Full Text] [Related]
7. Preventative and therapeutic effects of perindopril on hepatic fibrosis induced by bile duct ligation in rats.
Yeki M; Koda M; Matono T; Sugihara T; Maeda K; Murawaki Y
Mol Med Rep; 2009; 2(5):857-64. PubMed ID: 21475913
[TBL] [Abstract][Full Text] [Related]
8. The effects of the selective mineralocorticoid receptor antagonist eplerenone on hepatic fibrosis induced by bile duct ligation in rat.
Matono T; Koda M; Tokunaga S; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2010 Jun; 25(6):875-82. PubMed ID: 20428791
[TBL] [Abstract][Full Text] [Related]
9. Anti-fibrogenic effects of captopril and candesartan cilexetil on the hepatic fibrosis development in rat. The effect of AT1-R blocker on the hepatic fibrosis.
Tuncer I; Ozbek H; Ugras S; Bayram I
Exp Toxicol Pathol; 2003 Sep; 55(2-3):159-66. PubMed ID: 14620537
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of angiotensin blockade on hepatic fibrosis in common bile duct-ligated rats].
Park DH; Baik SK; Choi YH; Kim MY; Rhim DW; Kim JW; Kwon SO; Cho MY; Kim CH; Ahn SC
Korean J Hepatol; 2007 Mar; 13(1):61-9. PubMed ID: 17380076
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine.
Gordillo-Bastidas D; Oceguera-Contreras E; Salazar-Montes A; González-Cuevas J; Hernández-Ortega LD; Armendáriz-Borunda J
World J Gastroenterol; 2013 Dec; 19(47):9020-33. PubMed ID: 24379627
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of connective tissue growth factor by siRNA prevents liver fibrosis in rats.
Li G; Xie Q; Shi Y; Li D; Zhang M; Jiang S; Zhou H; Lu H; Jin Y
J Gene Med; 2006 Jul; 8(7):889-900. PubMed ID: 16652398
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes.
Gressner OA; Lahme B; Demirci I; Gressner AM; Weiskirchen R
J Hepatol; 2007 Nov; 47(5):699-710. PubMed ID: 17629588
[TBL] [Abstract][Full Text] [Related]
14. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
15. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
Xu W; Song S; Huang Y; Gong Z
J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
[TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms.
Biecker E; De Gottardi A; Neef M; Unternährer M; Schneider V; Ledermann M; Sägesser H; Shaw S; Reichen J
J Pharmacol Exp Ther; 2005 Jun; 313(3):952-61. PubMed ID: 15769867
[TBL] [Abstract][Full Text] [Related]
17. Dynamic expression of desmin, α-SMA and TGF-β1 during hepatic fibrogenesis induced by selective bile duct ligation in young rats.
Gonçalves JO; Tannuri AC; Coelho MC; Bendit I; Tannuri U
Braz J Med Biol Res; 2014 Oct; 47(10):850-7. PubMed ID: 25140817
[TBL] [Abstract][Full Text] [Related]
18. Liver fibrosis in bile duct-ligated rats correlates with increased hepatic IL-17 and TGF-β2 expression.
Zepeda-Morales AS; Del Toro-Arreola S; García-Benavides L; Bastidas-Ramírez BE; Fafutis-Morris M; Pereira-Suárez AL; Bueno-Topete MR
Ann Hepatol; 2016; 15(3):418-26. PubMed ID: 27049496
[TBL] [Abstract][Full Text] [Related]
19. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis.
Sedlaczek N; Jia JD; Bauer M; Herbst H; Ruehl M; Hahn EG; Schuppan D
Am J Pathol; 2001 Apr; 158(4):1239-44. PubMed ID: 11290541
[TBL] [Abstract][Full Text] [Related]
20. Candesartan, an angiotensin II receptor antagonist, suppresses pancreatic inflammation and fibrosis in rats.
Yamada T; Kuno A; Masuda K; Ogawa K; Sogawa M; Nakamura S; Ando T; Sano H; Nakazawa T; Ohara H; Nomura T; Joh T; Itoh M
J Pharmacol Exp Ther; 2003 Oct; 307(1):17-23. PubMed ID: 12944495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]